NCT00501228View on ClinicalTrials.gov

Tissue Repair in Stem Cell Transplant Recipients

NATerminatedINTERVENTIONAL

Enrollment

2

Participants

Timeline

Start Date

February 28, 2003

Primary Completion Date

September 30, 2008

Study Completion Date

September 30, 2008

Conditions

Graft-Versus-Host Disease

Interventions

DRUG

Filgrastim

5 mg/kg ID Once Daily x 1 Week

Trial Locations (1)

77030

U.T.M.D. Anderson Cancer Center, Houston

Sponsors

Collaborators (1)

All Listed Sponsors

collaborator

Amgen

INDUSTRY

lead

M.D. Anderson Cancer Center

OTHER